Complementary and Alternative Treatments in Psychiatry

Psychiatry: Third Edition

Volumn 2, Issue , 2008, Pages 2318-2353

  Brown, Richard P ^a   Gerbarg, Patricia L ^b   Muskin, Philip R ^a   Roose, Steven P ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Complementary and alternative medicine; Herbal remedies; Meditation; Neutraceuticals; Yoga; Yoga breathing

Indexed keywords

EID: 84875602278     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470515167.ch108     Document Type: Chapter

References (448)

1. Anonymous (1995) Melatonin. Medical Letter on Drugs and Therapeutics 37, 111-112.
2. Anonymous (2000) Drug interactions with St. John's wort. Medical Letter on Drugs and Therapeutics 42, 56.
3. Anonymous (2004) Bacopa monniera. Monograph. Alternative Medicine Review 9, 79-85.
4. Abou-Saleh MT and Coppen A (2006) Folic acid and the treatment of depression. Journal of Psychosomatic Research 61, 285-287.
5. Ackerman PT, Dykman RA, Holloway C, et al. (1991) A trial of piracetam in two subgroups of students with dyslexia enrolled in summer tutoring. Journal of Learning Disabilities 24, 542-549.
6. Agakishiev RS (1962) Longevity in Caucasian Republic of Dagestan. In Problems of Gerontology, Alpatov VV (ed). Moscow Publishing House of Academy of Sciences of the URRS, Moscow, Russia, pp 34-72.
7. Agnoli A, Andreoli V, Casacchia M, et al. (1976) Effect of s-adenosyl-L-methionine (SAMe) upon depressive symptoms. Journal of Psychiatric Research 13, 43-54.
8. Agricola R, Dalla Verde G, and Urani R (1994) S-adenosyl-l-methionine in the treatment of major depression complicating chronic alcoholism. Current Therapeutic Research 55, 83-92.
9. Akhondzadeh S and Abbasi SH (2006) Herbal medicine in the treatment of Alzheimer's disease. American Journal of Alzheimer's Disease and Other Dementias 21, 113-118.
10. Akhondzadeh S, Naghavi HR, Vazirian M, et al. (2001) Passionflower in the treatment of generalized anxiety: A pilot double-blind randomized controlled trial with oxazepam. Journal of Clinical Pharmacy and Therapeutics 26, 363-367.
11. Akhondzadeh S, Kashani L, Fotouhi A, et al. (2003) Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: A double-blind, randomized trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry 27, 123-127.
12. Akhondzadeh S, Fallah-Pour H, Afkham K, et al. (2004) Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial. BMC Complementary and Alternative Medicine 4, 12.
13. Akhondzadeh S, Mohammadi MR, and Khademi M (2004) Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial. BMC Psychiatry 4, 9.
14. Akhondzadeh BA, Moshiri E, Noorbala A A, et al. (2006) Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: A pilot double-blind randomized trial. Progress in NeuroPsychopharmacology and Biological Psychiatry.
15. Akhondzadeh S, Tahmacebi-Pour N, Noorbala AA, et al. (2005) Crocus sati-vus L. in the treatment of mild to moderate depression: A double-blind, randomized and placebo-controlled trial. Phytotherapy Research 19, 148-151.
16. Almeida JC and Grimsley EW (1996) Coma from the health food store: Interaction between kava and alprazolam. Annals of Internal Medicine 125, 940-941.
17. Alvarez XA, Mouzo R, Pichel V, et al. (1999) Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion. Methods and Findings in Experimental and Clinical Pharmacology 21, 633-644.
18. Amaducci L (1988) Phosphatidylserine in the treatment of Alzheimer's disease: Results of a multicenter study. Psychopharmacology Bulletin 24, 130-134.
19. Andreatini R, Sartori VA, Seabra ML, et al. (2002) Effect of valepotriates (valerian extract) in generalized anxiety disorder: A randomized placebo-controlled pilot study. Phytotherapy Research 16, 650-654.
20. Arciniegas DB (2001) Traumatic brain injury and cognitive impairment: The cholinergic hypothesis. Neuropsychiatry Reviews, 17-20.
21. Arciniegas DB (2003) The cholinergic hypothesis of cognitive impairment caused by traumatic brain injury. Current Psychiatry Reports 5(5), 391-399.
22. Arciniegas DB and Silver JM (2006) Pharmacotherapy of posttraumatic cognitive impairments. Behavioural Neurology 17(1), 25-42.
23. Arendt J (1997) Jet lag/night shift, blindness and melatonin. Transactions of the Medical Society of London 114, 7-9.
24. Arnold LE (2001) Alternative treatments for adults with attention-deficit hyperactivity disorder (ADHD). Annals of the New York Academy of Sciences 931, 310-341.
25. Arnold LE and DiSilvestro RA (2005) Zinc in attention-deficit/hyperactiv-ity disorder. Journal of Child and Adolescent Psychopharmacology 15, 619-627.
26. Antalis CJ, Stevens LJ, Campbell M, et al. (2006) Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 75, 299-308.
27. Ayers ME (1987) Electroencephalographic neurofeedback and closed head injury of 250 individuals. In National Head Injury Syllabus. Washington National Head Injury Foundation, Washington, DC, USA, pp 380-392.
28. Bacci Ballerini F, Lopez Anguera A, Alcaraz P, et al. (1983) Treatment of postconcussion syndrome with S-adenosylmethionine. Medicina Clinica 80, 161-164.
29. Bandelow B, Sievert K, Rothemeyer M, et al. (1995) What treatments do patients with panic disorder and agoraphobia get? European Archives of Psychiatry and Clinical Neuroscience 245, 165-171.
30. Barcelo HA, Wiemeyer JC, Sagasta CL, et al. (1987) Effect of S-adenosylmethionine on experimental osteoarthritis in rabbits. American Journal of Medicine 83, 55-59.
31. Beauchaine T (2001) Vagal tone, development, and Gray's motivational theory: Toward an integrated model of autonomic nervous system functioning in psychopathology. Development and Psychopathology 13, 183-214.
32. Beauregard M and Levesque J (2006) Functional magnetic resonance imaging investigation of the effects of neurofeedback training on the neural bases of selective attention and response inhibition in children with attention-deficit/hyperactivity disorder. Applied Psychophysiology and Biofeedback 31(1), 3-20.
33. Becerra J, Fernandez T, Harmony T, et al. (2006) Follow-up study of learning-disabled children treated with neurofeedback or placebo. Clinical EEG and Neuroscience 37(3), 198-203.
34. Bechara A, Damasiao H, Tranel D, et al. (1997) Deciding advantageously before knowing the advantageous strategy. Science 275, 1293-1295.
35. Bell IR, Morrow FD, Read M, et al. (1992) Low thyroxine levels in female psychiatric inpatients with riboflavin deficiency: Implications for folate-dependent methylation. Acta Psychiatrica Scandinavica 85, 360-363.
36. Bell KM, Potkin SG, Carreon D, et al. (1994) S-adenosylmethionine blood levels in major depression: Changes with drug treatment. Acta Neuro-logica Scandinavica Supplementum 154, 15-18.
37. Bell MJ, Kochanek PM, Carcillo JA, et al. (1998) Interstitial adenosine, ino-sine, and hypoxanthine are increased after experimental traumatic brain injury in the rat. Journal of Neurotrauma 15, 163-170.
38. Bellon A (2006) Searching for new options for treating insomnia: Are melatonin and ramelteon beneficial? Journal of Psychiatric Practice 12, 229-243.
39. Bender KJ (2000) Investigating inositol in psychiatry. Psychiatric Times 41-46.
40. Benjamin J, Agam G, Levine J, et al. (1995a) Inositol treatment in psychiatry.Psychopharmacology Bulletin31, 167-175.
41. Benjamin J, Levine J, Fux M, et al. (1995b) Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder.American Journal of Psychiatry152, 1084-1086.
42. Benson H, Greenwood MM, and Klemchuk H (1975) The relaxation response: Psychophysiologic aspects and clinical applications. International Journal of Psychiatry in Medicine 6, 87-98.
43. Bent S, Padula A, Moore D, et al. (2006) Valerian for sleep: A systematic review and meta-analysis. American Journal of Medicine 119, 1005-1012.
44. Benson H, Malhotra MS, Goldman RF, et al. (1990) Three case reports of the metabolic and electroencephalographic changes during advanced Buddhist meditation techniques. Behavioral Medicine 16, 90-95.
45. Benton D, Griffiths R, and Haller J (1997) Thiamine supplementation mood and cognitive functioning. Phsychopharmacology 129, 66-71.
46. Benton D, Haller J, and Fordy J (1995) Vitamin supplementation for 1 year improves mood. Neuropsychobiology 32, 98-105.
47. Berlanga C, Ortega-Soto HA, Ontiveros M, et al. (1992) Efficacy of S-adenosyl-l-methionine in speeding the onset of action of imipramine. Psychiatry Research 44, 257-262.
48. Bernardi L, Porta C, Spicuzza L, et al. (2005) Cardiorespiratory interactions to external stimuli. Archives Italiennes De Biologie 143, 215-221.
49. Berntson GG, Sarter M, and Cacioppo JT (1998) Anxiety and cardiovascular reactivity: The basal forebrain cholinergic link. Behavioural Brain Research 94, 225-248.
50. Bersani G and Garavini A (2000) Melatonin add-on in manic patients with treatment resistant insomnia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 24, 185-191.
51. Bhatia M, Kumar A, Kumar N, et al. (2003) Electrophysiologic evaluation of Sudarshan Kriya: An EEG, BAER, P300 study. Indian Journal of Physiology and Pharmacology 47(2), 157-163.
52. Bikov VA, Zapesochnaya GG, and Kurkin VA (1999) Rhodiola rosea: Traditional and biotechnological aspects of obtaining medicinal and pharmacological compounds. Pharmacology and Toxicology Medicinal Plants 22-39.
53. Bilici M, Yildirim F, Kandil S, et al. (2004) Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 28, 181-190.
54. Birch EE, Garfield S, Hoffman DR, et al. (2000) A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Developmental Medicine and Child Neurology 42, 174-181.
55. Blumenthal M, Brinckmann J, and Wellschlaeger B (2003) The ABC Clinical Guide to herbs. American Botanical Council, Austin, TX, USA.
56. Bonoczk P, Gulyas B, Adam-Vizi V, et al. (2000) Role of sodium channel inhibition in neuroprotection: Effect of vinpocetine. Brain Research Bulletin 53, 245-254.
57. Bottiglieri T (1997) Ademetionine (S-adenosylmethionine) neuropharmacology: Implications for drug therapies in psychiatric and neurological disorders. Expert Opinion on Investigational Drugs 6, 417-426.
58. Bottiglieri T (1996) Folate, vitamin B12, and neuropsychiatric disorders. Nutrition Reviews 54, 382-390.
59. Bottiglieri T and Hyland K (1994) S-adenosylmethionine levels in psychiatric and neurological disorders: A review. Acta Neurologica Scandinavica Supplementum 154, 19-26.
60. Bottiglieri T, Godfrey P, Flynn T, et al. (1990) Cerebrospinal fluid S-ade-nosylmethionine in depression and dementia: Effects of treatment with parenteral and oral S-adenosylmethionine. Journal of Neurology, Neurosurgery and Psychiatry 53, 1096-1098.
61. Bottiglieri T, Laundy M, Crellin R, et al. (2000) Homocysteine, folate, meth-ylation, and monoamine metabolism in depression. Journal of Neurology, Neurosurgery, and Psychiatry 69, 228-232.
62. Bourre JM (2005) Dietary omega-3 Fatty acids and psychiatry: Mood, behaviour, stress, depression, dementia and aging. Journal of Nutrition, Health and Aging 9, 31-38.
63. Bourre JM (2006) Effects of nutrients (in food) on the structure and function of the nervous system: Update on dietary requirements for brain. Part 2: Macronutrients. Journal of Nutrition, Health and Aging 10, 386-399.
64. Breckhman II and Dardymov IV (1969) New substances of plant origin which increase non-specific resistance. Annual Review of Pharmacology 9, 419-430.
65. Bressa GM (1994) S-adenosyl-l-methionine (SAMe) as antidepressant: Meta-analysis of clinical studies. Acta Neurologica Scandinavica Sup-plementum 154, 7-14.
66. Brichenko VS and Skorokhova TF (1987) Herbal adaptogens in rehabilitation of patients with depression, clinical and organisational aspects of early manifestations of nervous and mental diseases. Barnaul 15.
67. Brown D (1996) Anti-anxiety effects of chamomile compounds. Herbal-gram 39, 19.
68. Brown RP and Gerbarg PL (2000) Integrative psychopharmacology: A practical approach to herbs and nutrients in psychiatry. In Comlemen-tary and Alternative Medicine and Psychiatry. Review of Psychiatry, Vol. 19. Muskin PR (Vol. ed), Oldham JM and Riba MB (Ser. eds). American Psychatric Association Press, Inc, Washington, DC, USA.
69. Brown RP and Gerbarg PL (2004) The Rhodiola Revolution. Rodale Press, New York, NY, USA.
70. Brown RP and Gerbarg PL (2005a) Sudarshan Kriya Yoga Breathing in the treatment of stress, anxiety, and depression: Part I-Neurophysi-ological model.Journal of Complementary and Alternative Medicine11, 189-201.
71. Brown RP and Gerbarg PL (2005b) Sudarshan Kriya Yoga Breathing in the treatment of stress, anxiety, and depression: Part II: Clinical Applications and Guidelines.Journal of Complementary and Alternative Medicine11, 711-717.
72. Brown RP, Gerbarg PL, and Bottiglieri T (2000) S-Adenosylmethionine (SAMe) in the clincial practice of psychiatry, neurology, and internal medicine. Clinical Practice of Alternative Medicine 1, 230-241.
73. Brown RP, Gerbarg PL, and Ramazanov Z (2002) A Phythomedical Review of Rhodiola rosea. Herbalgram 56, 40-62.
74. Brown RP, Gerbarg PL, and Muskin PR (in press) How to Use Herbs, Nutrients, and Yoga in Mental Health Care. W W Norton & Company, New York, NY, USA.
75. Bucci W (2003) Varieties of dissociative experiences: A multiple code account and a discussion of Bromberg's case of "William. " Psychoanalytic Psychology 20, 542-557.
76. Burns NR, Bryan J, and Nettelbeck T (2006) Ginkgo biloba: No robust effect on cognitive abilities or mood in healthy young or older adults. Human Psycho pharmacology 21, 27-37.
77. Buscemi N, Vandermeer B, Hooton N, et al. (2005) The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. Journal of General Internal Medicine 20(12), 1151-1158.
78. Butnik SM (2005) Neurofeedback in adolescents and adults with attention deficit hyperactivity disorder. Journal of Clinical Psychology 61, 621-625.
79. Caffarra C and Santamaria V (1987) The effects of phosphatidylserine in patients with mild cognitive decline: An open trial. Clinical Trials Journal 24, 109-111.
80. Calabrese P, Perrault H, Dinh TP, et al. (2000) Cardiorespiratory interactions during resistive load breathing. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 279, R2208-R2213.
81. Calatayud Maldonado V, Calatayud Perez JB, Aso Escario J (1991) Effects of CDP-choline on the recovery of patients with head injury. Journal of the Neurological Sciences 103 (Suppl.), S15-S18.
82. Cantoni GL (1952) The nature of the active methyl donor formed enzymatically from l-methionine and adenosinetriphosphate. Journal of the American Chemical Society 74, 2942-2943.
83. Cappo BM and Holmes DS (1984) The utility of prolonged respiratory exhalation for reducing physiological and psychological arousal in non-threatening and threatening situations. Journal of Psychosomatic Research 28, 265-273.
84. Carney MW and Ellis PF (1988) Benzodiazepines in anxiety. Lancet 1 (8584), 537.
85. Carney MW, Chary TK, Bottiglieri T, et al. (1989) The switch mechanism and the bipolar/unipolar dichotomy. British Journal of Psychiatry 154, 48-51.
86. Carney RM, Saunders RD, Freedland KE, et al. (1995) Association of depression with reduced heart rate variability in coronary artery disease. American Journal of Cardiology. 76(8), 562-564.
87. Carney MW, Toone BK, and Reynolds EH (1987) S-adenosylmethio-nine and affective disorder. American Journal of Medicine 83, 104-106.
88. Carrieri PB, Indaco A, and Gentile S (1990) S-Adenosylmethionine treatment of depression in patients with Parkinson's disease: A double-blind crossover study versus placebo. Current Therapeutic Research 48, 154-160.
89. Carter JJ and Byrne GG (2006) PTSD Australian Vietnam Veterans: Yoga adjunct treatment, two RCT's: MCYI and SKY. Proceedings World Conference Expanding Paradigms: Science, Consciousness and Spirituality. All India Institute of Medical Sciences, New Delhi, India, February 24-25, pp. 49-62.
90. Carter JJ and Byrne GG (2004) A two year study of the use of Yoga in a series of pilot studies as an adjunct to ordinary psychiatric treatment in a group of Vietnam War Veterans suffering from Post Traumatic Stress Disorder. http://www.therapywithyoga.com. Accessed January 10, 2005.
91. Cenacchi T, Bertoldin T, and Palin E (1987) Human tolerability of phosphatidyl serine assessed through laboratory examinations. Clinical Trials Journal 24, 125-130.
92. Cerutti R, Sichel MP, Perin M, et al. (1993) Psychological distress during puerperium: A novel therapeutiapproach using S-adenosylmethionine. Current Therapeutic Research 53, 707-716.
93. Cicerchia G, Santucci R, and Palmieri M (1985) Use of piracetam in the treatment of cranial injuries. Observations on 903 cases. Clinica Terapeu-tica 114, 481-487.
94. Clough AR, Bailie RS, and Currie B (2003) Liver function test abnormalities in users of aqueous kava extracts. Journal of Toxicology. Clinical Toxicology 41, 821-829.
95. Cohen MH and Schouten R (2007) Legal, Regulatory, and Ethical Issues in Complementary and Alternative Treatments in Mental Health Care, Lake JH and Spiegel D (eds). American Psychiatric Press, Inc., Washington, DC, USA, pp 21-36.
96. Co hen-Mansfield J, Garfinkel D, and Lipson S (2000) Melatonin for treatment of sundowning in elderly persons with dementia-a preliminary study. Archives of Gerontology and Geriatrics 31, 65-76.
97. Colell A, Garcia-Ruiz C, Morales A, et al. (1997) Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanol-treated rats: Effect of membrane physical properties and S-adenosyl-1-methionine. Hepatology 26, 699-708.
98. Conant R and Schauss AG (2004) Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: A review of the literature. Alternative Medicine Review 9, 17-31.
99. Connor KM, Payne V, and Davidson JR (2006) Kava in generalized anxiety disorder: Three placebo-controlled trials. International Clinical Psychopharmacology 21, 249-253.
100. Conquer JA, Tierney MC, Zecevic J, et al. (2000) Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 35, 1305-1312.
101. ConsumerLab.com.(2001) Product Review: St. John's wort.
102. Cooney CA, Wise CK, Poirier LA, et al. (1998) Methamphetamine treatment affects blood and liver S-adenosylmethionine (SAM) in mice. Correlation with dopamine depletion in the striatum. Annals of the New York Academy of Sciences 844, 191-200.
103. Coppen A and Bailey J (2000) Enhancement of the antidepressant action of fluoxetine by folic acid: A randomised, placebo controlled trial. Journal of Affective Disorders 60, 121-130.
104. Cott JM (2002) Herb-drug interactions: Focus on pharmacokinetics. CNS Spectrum 6, 827-832.
105. Cott JM and Fugh-Berman A (1998) Is St. John's wort (Hypericum perforatum) an effective antidepressant? Journal of Nervous and Mental Disease 186, 500-501.
106. Cozens DD, Barton QJ, Clark R, et al. (1988) Reproductive toxicity studies of ademetionine. Arzneimittelforschung 38, 1625-1629.
107. Craig AD (2003) Interoception: The sense of the physiological condition of the body. Current Opinion in Neurobiology 13, 500-505.
108. Crawford MA, Doyle W, and Leaf A (1993) Nutritional and neurodevelp-mental disorders. Nutrition and Health 9, 81-97.
109. Crellin R, Bottiglieri T, and Reynolds EH (1993) Folates and psychiatric disorders. Clinical potential. Drugs 45, 623-636.
110. Criconia AM, Araquistain JM, Daffina N, et al. (1994) Results of treatment with S-adenosyl-l-methionine in patients with major depression and internal illnesses. Current Therapeutic Research 55, 666-674.
111. Critchley HD (2005) Neural mechanisms of autonomic affective, and cognitive integration. Journal of Comparative Neurology 93, 154-166.
112. Crook TH, Tinklenberg J, Yesavage J, et al. (1991) Effects of phosphatidyl-serine in age-associated memory impairment. Neurology 41, 644-649.
113. Crook T, Petrie W, Wells C, et al. (1992) Effects of phosphatidylserine in Alzheimer's disease. Psychopharmacology Bulletin 28, 61-66.
114. Czyrak A, Rogoz Z, Skuza G, et al. (1992) Antidepressant activity of S-adenosyl-l-methionine in mice and rats. Journal of Basic and Clinical Physiology and Pharmacology 3, 1-17.
115. Damasio AR (1999) The feeling of what happens: Body and emotion in the making of consciousness. Harcourt Brace, New York, NY, USA.
116. Darbinyan VA, Aslanyan G, Embroyan E, et al. (2007) SHR-5 and the treatment of depression. Nordic Journal of Psychiatry 61, 5.
117. Das P, Kemp AH, Liddell BJ, et al. (2005) Pathways for fear perception: Modulation of amygdala activity by thalamo-cortical systems. Neuroimage 26, 141-148.
118. Davidson J and the Hypericum Depression Trial Study Group (2002) Effect of Hypericum perforatum (St. John's wort) in major depressive disorder: A randomized controlled trial. Journal of the American Medical Association 287(4), 1807-1814.
119. Davidson RJ, Kabat-Zinn J, Schumacher J, et al. (2003) Alterations in brain and immune function produced by mindfulness meditation. Psychosomatic Medicine 65(4), 564-570.
120. De Deyn PP, Reuck JD, Deberdt W, et al. (1997) Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group. Stroke 28, 2347-2352.
121. De La Cruz JP, Pavia J, Gonzalez-Correa JA, et al. (2000) Effects of chronic administration of S-adenosyl-l-methionine on brain oxidative stress in rats. Naunyn-Schmiedebergs Archives of Pharmacology 361, 47-52.
122. De Smet PA (2002) Herbal remedies. New England Journal of Medicine 347, 2046-2056.
123. De Smet PA (2007) Clinical risk management of herb-drug interactions. British Journal of Clinical Pharmacology 63(3), 258-267.
124. Delle Chiale R and Boissard G (1997) Meta-analysis of 2 European multicenter controlled trials with ademetionine (SAMe) in major depression [abstract 90-56]. Biological Psychiatry 42, 245S.
125. Delle Chiale R, Panccheri P, and Scapicchio P (2000a) MC3: Multicenter controlled efficacy and safety trial of oral S-adenosyl-methionine (SAMe) vs.oral imipramine in the treatment of depression. Collegium Internationale Neuro-Psychopharmacologisum (CINP). Brussels, Belgium, July 9-13.
126. Delle Chiale R, Panccheri P, and Scapicchio P (2000b). MC4: Multicenter controlled efficacy and safety trial of intramuscular S-adenosyl-methionine (SAMe) vs. oral imipramine in the treatment of depression. Collegium Internationale Neuro-Psychopharmacologisum (CINP).Brussels, Belgium, July 9-13.
127. DeMott K (1998) St. John's wort tied to serotonin syndrome. Clinical Psychiatry News 28.
128. Descilo T, Vedamurthachar A, Gerbarg PG, et al. (2006) Comparison of a yoga breath-based program and a client-centered exposure therapy for relief of PTSD and depression in survivors of tsunami disaster. Proceedings World Conference Expanding Paradigms: Science Consciousness and Spirituality. All India Institute of Medical Sciences, New Delhi, India, pp 64-78.
129. Di Benedetto P, Iona LG, and Zidarich V (1993) Clinical evaluation of S-adenosyl-L-methionine versus transcutaneous electrical nerve stimulation in primary fibromyalgia. Current Therapeutic Research 53, 222-229.
130. Di Padova C, Giudici A, and Boissard G (2000) Ademetionine and depression. In V Workshop on Methionine Metabolism: Molecular Mechanisms and Clinical Implications, February 20-24, Mato JM and Caballero A, (eds), University of Navarre, Madrid, Spain, pp 294-299.
131. Diamond BJ, Shiflett SC, Feiwel N, et al. (2000) Ginkgo biloba extract: Mechanisms and clinical indications. Archives of Physical Medicine and Rehabilitation 81, 668-678.
132. Dixon CE, Ma X, and Marion DW (1997) Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release. Journal of Neurotrauma 14, 161-169.
133. Dodge NN and Wilson GA (2001) Melatonin for treatment of sleep disorders in children with developmental disabilities. Journal of Child Neurology 16(8), 581-584.
134. Dolberg OT, Hirschmann S, and Grunhaus L (1998) Melatonin for the treatment of sleep disturbances in major depressive disorder. American Journal of Psychiatry 155, 1119-1121.
135. Donath F, Quispe S, Diefenbach K, et al. (2000) Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 33, 47-53.
136. Dorofeev BF and Kholodov LE (1991) Pikamilon pharmacokinetics in animals. Farmakologiia i Toksikologiia 54, 66-69.
137. Dos Santos-Neto LL, de Vilhena Toledo MA, Medeiros-Souza P, et al. (2006) The use of herbal medicine in Alzheimer's disease-a systematic review. Evidence-based Complementary and Alternative Medicine 3, 441-445.
138. Dowling GA, Mastick J, Colling E, et al. (2005) Melatonin for sleep disturbances in Parkinson's disease. Sleep Medicine 6, 459-466.
139. Dubichev AG, Kurkin BA, Zapesochnaya GG, et al. (1991) Study of Rhodi-ola rosea root chemical composition using HPLC. Cemico-Pharmaceuti-cal Journal 2, 188-193.
140. Dunnick JK and Hailey JR (1995) Experimental studies on the long-term effects of methylphenidate hydrochloride. Toxicology 103, 77-84.
141. Eisenberg DM, Davis RB, Ettner SL, et al. (1998) Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. Journal of the American Medical Association 280, 1569-1575.
142. Elias MF, Robbins MA, Budge MM, et al. (2006) Homocysteine, folate, and vitamins B6 and B12 blood levels in relation to cognitive performance: The Maine-Syracuse study. Psychosomatic Medicine 68, 547-554.
143. Enderby P, Broeckx J, Hospers W, et al. (1994) Effect of piracetam on recovery and rehabilitation after stroke: A double-blind, placebo-controlled study. Clinical Neuropharmacology 17, 320-331.
144. Ernst E and Pittler MH (2000) The efficacy and safety of feverfew (Tan-acetum parthenium L. ): An update of a systematic review. Public Health Nutrition 3, 509-514.
145. Ernst E, Pittler MH, Stevinson C, et al. (eds) (2001) The Desktop Guide to Complementary and Alternative Medicine. Mosby, New York, NY USA.
146. Evans PJ, Whiteman M, Tredger JM, et al. (1997) Antioxidant properties of S-adenosyl-L-methionine: A proposed addition to organ storage fluids. Free Radical Biology and Medicine 23, 1002-1008.
147. Fauteck J, Schmidt H, Lerchl A, et al. (1999) Melatonin in epilepsy: First results of replacement therapy and first clinical results. Biological Signals and Receptors 8, 105-110.
148. Fava M, Alpert J, Nierenberg AA, et al. (2005) A double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder. Journal of Clinical Psychopharmacology 25, 441-447.
149. Fava M, Rosenbaum JF, Birnbaum R, et al. (1992) The thyrotropin response to thyrotropin-releasing hormone as a predictor of response to treatment in depressed outpatients. Acta Psychiatrica Scandinavica 86, 42-45.
150. Fava M, Borus JS, Alpert JE, et al. (1997) Folate, Vitamin B12 and homocysteine in major dipressive disorder. American Journal of Psychiatry 154, 426-428.
151. Fehmi LG and McKnight JT (2001) Attention and neurofeedback synchrony training: Clinical results and their significance. Journal of Neu-rotherpy 5.
152. Ferrell RE, Salamatina NV, Dalakishvili SM, et al. (1985) A population genetic study in the Ochamchir region, Abkhazia, SSR. American Journal of Physical Anthropology 66, 63-71.
153. Finkelstein JD (1998) The metabolism of homocysteine: Pathways and regulation. European Journal of Pediatrics 157 (Suppl. 2), S40-S44.
154. Flicker L and Grimley EG (2001) Piracetam for dementia or cognitive impairment. The Cochrane Database of Systematic Reviews 2, CD001011.
155. Fontanari D, Di Palma C, Giorgetti G, et al. (1994) Effects of S-adenosyl-l-methionine on cognitive and vigilance functions in the elderly. Current Therapeutic Research 55, 682-689.
156. Fox DJ, Tharp DF, and Fox LC (2005) Neurofeedback: An alternative and efficacious treatment for attention deficit hyperactivity disorder. Applied Psychophysiology and Biofeedback 30, 365-73.
157. Frangou S, Lewis M, and McCrone P (2006) Efficacy of ethyl-eicosapentae-noic acid in bipolar depression: Randomised double-blind placebo-controlled study. British Journal of Psychiatry 188, 46-50.
158. Franzblau SH, Smith M, Echevarria S, et al. (2006) Take a breath, break the silence: The effects of yogic breathing and testimony about battering on feelings of self-efficacy in battered women. International Journal of Yoga Therapy 16, 49-57.
159. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, et al. (2006) Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: SA randomized double-blind trial. Archives of Neurology 63, 1402-1408.
160. Frezza M, Surrenti C, Manzillo G, et al. (1990) Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study. Gastroenterology 99, 211-215.
161. Friedel HA, Goa KL, and Benfield P (1989) S-adenosyl-l-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism. Drugs 38, 389-4416.
162. Fugh-Berman A (2000) Herb-drug interactions. Lancet 355, 134-138.
163. Furmanowa M, Oledzka H, Michalska M, et al. (1995)Rhodiola rosea L. (Roseroot): in vitro regeneration and the biological activity of roots. In Biotechnology in Agriculture and Forestry, Vol. 33. Medicinal and aromatic plants VIII, Bajaj YPS (ed). Springer-Verlag, Berlin Heidelberg, pp 412-426.
164. Furmanowa M, Skopinska-Rozewska E, Rogala E, et al. (1998) Rhodiola rosea in vitro culture-phytochemical analysis and antioxidant action. Acta Societis Botanicorum Poloniae 76, 69-73.
165. Gaster B and Holroyd J (2000) St. John's wort for depression: A systematic review. Archives of Internal Medicine 160, 152-156.
166. Gastpar M, Singer A, and Zeller K (2005) Efficacy and tolerability of hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertraline. Pharmacopsychiatry 38(2), 78-86.
167. Gelenberg AJ (2000) St. John's Wort Update. Biological Therapies in Psychiatry 23, 22-24.
168. Gerbarg P (2007) Yoga and Neuro-psychoanalysis. In Bodies in Treatment: The Unspoken Dimension, Anderson FS (ed). The Analytic Press, Inc, Hillsdale, NJ, USA.
169. Gerbarg PL and Brown RP (2005) Yoga: A breath of relief for Hurricane Katrina refugees. Current Psychiatry 4, 55-67.
170. Germano C, Ramazanov Z, and Bernal Suarez M (1999) Arctic Root (Rhodiola rosea); the Powerful New Ginseng Alternative. Kensington Publishing Corp., New York, NY, USA.
171. Giulidori P and Di Padova C (2000) Effect of SAMe administration on plasma homocysteine in humans. In V Workshop on Methionine Metabolism: Molecular Mechanisms and Clinical Implications, February 20-24, Mato JM and Caballero A (eds). Granada, Madrid, Spain, pp 316-320.
172. Glieck J (1988) Chaos: The Making of Science. Penguin, New York, NY, USA.
173. Goldberg JF and Garno JL (2005) Development of posttraumatic stress disorder in adult bipolar patients with histories of severe childhood abuse. Journal of Psychiatric Research 39, 595-601.
174. Gordon JS, Staples JK, Blyta A, et al. (2004) Treatment of posttraumatic stress disorder in postwar Kosovo high school students using mind-body skills group: A pilot study. Journal of Traumatic Stress 17, 143-147.
175. Gouliaev AH and Senning A (1994) Piracetam and other structurally related nootropics. Brain research. Brain research reviews 19, 180-222.
176. Granath J, Ingvarsson S, von Thiele U, et al. (2006) Stress management: A randomized study of cognitive behavioural therapy and yoga. Cognitive Behaviour Therapy 35, 3-10.
177. Grassetto M and Varatto A (1994) Primary Fibromyalgia is responsive to S-adenosyl-l-methionine. Current Therapeutic Research 55, 797-806.
178. Guderian S and Duzel E (2005) Induced theta oscillations mediate large-scale synchrony with mediotemporal areas during recollection in humans. Hippocampus 15, 901-912.
179. Gurnell EM and Chatterjee VK (2001) Dehydroepiandrosterone replacement therapy. European Journal of Endocrinology/European Federation of Endocrine Societies 145, 103-106.
180. Haffner J, Roos J, Goldstein N, et al. (2006) The effectiveness of body-oriented methods of therapy in the treatment of attention-deficit hyperactivity disorder (ADHD): Results of a controlled pilot study. Zeitschrift Fur Kinder-Und Jugendpsychiatrie Und Psychotherapie 34, 37-47.
181. Haimov I, Lavie P, Laudon M, et al. (1995) Melatonin replacement therapy of elderly insomniacs. Sleep 18, 598-603.
182. Hakkarainen H and Hakamies L (1978) Piracetam in the treatment of post-concussional syndrome. A double-blind study. European Neurology 17, 50-55.
183. Hansgen KD, Vesper J, and Ploch M (1994) Multicenter double-blind study examining the antidepressant effectiveness of the hypericum extract LI 160. Journal of Geriatric Psychiatry and Neurology 7 (Suppl. 1), S15-S18.
184. Hassing L, Wahlin A, Winblad B, et al. (1999) Further evidence of the effects of vitamin B12 and folate levels on episodic memory functioning: A population-based study of healthy very old adults. Biological Psychiatry 45, 1472-1480.
185. Hawkins EB (2000) Report on Houghton PJ: Leads to treatment of CNS disorders with plants, extracts and constituents. Poster presentation, 48th Annual Meeting of the International Congress of the Society of Plant Research PL12, September 5, Herbalgram 50, 71.
186. Hayes RL and Dixon CE (1994) Neurochemical changes in mild head injury. Seminars in Neurology 14, 25-31.
187. Hebert R, Lehmann D, Tan G, et al. (2005) Enhanced EEG alpha time-domain phase synchrony during Transcendental Meditation: Implications for cortical integration theory. Signal Processing 1-20.
188. Helfgott E, Rudel RG, and Kairam R (1986) The effect of piracetam on short-and long-term verbal retrieval in dyslexic boys. International Journal of Psychophysiology 4, 53-61.
189. Herxheimer A and Petrie KJ (2001) Melatonin for preventing and treating jet lag. Cochrane Database of Systematic Reviews (1), CD001520.
190. Hibbeln JR and Salem N Jr. (1995) Dietary polyunsaturated fatty acids and depression: When cholesterol does not satisfy. American Journal of Clinical Nutrition 62, 1-9.
191. Hibbeln JR, Umhau J, and George D (1997) Do plasma polyunsaturates predict hostility and depression? World Review of Nutrition and Dietetics 82, 175-186.
192. Holguin F, Tellez-Rojo MM, Lazo M, et al. (2005) Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest 127, 1102-1107.
193. Holtmann M and Stadler C (2006) Electroencephalographic biofeedback for the treatment of attention-deficit hyperactivity disorder in childhood and adolescence. Expert Rev Neurother 6, 533-540.
194. Hu Z, Yang X, Ho PC, et al. (2005) Herb-drug interactions: A literature review. Drugs 65, 1239-1282.
195. Hurtado O, Moro MA, Cardenas A, et al. (2005) Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: Effects on glutamate transport. Neurobiology of Disease 18, 336-345.
196. Innes KE, Bourguignon C, and Taylor AG (2005) Risk indices associated with the insulin resistance syndrome, cardiovascular disease, and possible protection with yoga: A systematic review. Journal of the American Board of Family Practice 18, 491-519.
197. Itil TM (2001) Uses and contraindications of Ginkgo biloba in psychiatry. Psychiatric Times 47-48.
198. Itil TM, Menon GN, Songar A, et al. (1986) CNS pharmacology and clinical therapeutic effects of oxiracetam. Clinical Neuropharmacology 9 (Suppl. 3), S70-S72.
199. Itil TM, Eralp E, Ahmed I, et al. (1998) The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine. Psychopharmacology Bulletin 34, 391-397.
200. Jacobs BP, Bent S, Tice JA, et al. (2005) An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia. Medicine (Baltimore) 84, 197-207.
201. Jan JE, Espezel H, and Appleton RE (1994) The treatment of sleep disorders with melatonin. Developmental Medicine and Child Neurology 36, 97-107.
202. Janakiramaiah N, Gangadhar BN, Naga Venkatesha Murthy PJ, et al. (1998) Therapeutic efficacy of Sudarshan Kriya Yoga (SKY) in dysthymic disorder. NIMHANS Journal 21-28.
203. Janakiramaiah N, Gangadhar BN, Naga Venkatesha Murthy PJ, et al. (2000) Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: A randomized comparison with electroconvulsive therapy (ECT) and imipramine. Journal of Affective Disorders 57, 255-259.
204. Jensen CL, Chen H, Fraley JK, et al. (1996) Biochemical effects of dietary linoleic/alpha-linolenic acid ratio in term infants. Lipids 31, 107-113.
205. Jensen PS and Kenny DT (2004) The effects of yoga on the attention and behavior of boys with Attention-Deficit/hyperactivity Disorder (ADHD). Journal of Attention Disorder 7, 205-216.
206. Jin P (1989) Changes in heart rate, noradrenaline, cortisol and mood during Tai Chi. Journal of Psychosomatic Research 33, 197-206.
207. Jonte A, Brockmuller J, Bauer S, et al. (1999) Pharmacokinetic interaction of digoxin with an herbal extract from St. John's Wort. Clinical Pharmacology and Therapeutics 66, 338-345.
208. Kagan BL, Sultzer DL, Rosenlicht N, et al. (1990) Oral S-adenosylmethio-nine in depression: A randomized, double-blind, placebo-controlled trial. American Journal of Psychiatry 147, 591-595.
209. Kahn EM (2004) "Ha" "Ou ka Leo O ka Pu" The voice of the shell sounds Breath! Honolulu. Zen Care, Hawaii.
210. Kang SY, Kim SH, Schini VB, et al. (1995) Dietary ginsenosides improve endothelium-dependent relaxation in the thoracic aorta of hypercholes-terolemic rabbit. General Pharmacology 26, 483-487.
211. Kasper S, Anghelescu IG, Szegedi A, et al. (2006) Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: A randomized, double-blind, placebo-controlled, multi-center trial. BMC Medicine 4, 14.
212. Kayumov L, Brown G, Jindal R, et al. (2001) A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome. Psychosomatic Medicine 63, 40-48.
213. Kelly GS (2001) Rhodiola rosea: A possible plant adaptogen. Alternative Medicine Review 6, 293-302.
214. Kennedy DO, Wake G, Savelev S, et al. (2003) Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology 28, 1871-1881.
215. Kennedy DO, Little W, and Scholey AB (2004) Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosomatic Medicine 66, 607-613.
216. Kenny E, Muskin PR, Brown R, et al. (2001) What the general psychiatrist should know about herbal medicine. Current Psychiatry Reports 3, 226-234.
217. Kessler J, Thiel A, Karbe H, et al. (2000) Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. Stroke 31, 2112-2116.
218. Khalsa SB and Cope S (2006) Effects of a yoga lifestyle intervention on performance-related characteristics of musicians: A preliminary study. Medical Science Monitor 12, CR325-CR331.
219. Kidd PM (2000) Attention deficit/hyperactivity disorder (ADHD) in children: Rationale for its integrative management. Alternative Medicine Review 5, 402-428.
220. Kim HL, Streltzer J, and Goebert D (1999) St. John's wort for depression; a meta-analysis of well-defined clinical trials. Journal of Nervous and Mental Disease 187, 532-539.
221. Kirkwood G, Rampes H, Tuffrey V, et al. (2005) Yoga for anxiety: A systematic review of the research evidence. British Journal of Sports Medicine 39, 884-891.
222. Kitani K, Minami C, Maruyama W, et al. (2000) Common properties for propargylamines of enhancing superoxide dismutase and catalase activities in the dopaminergic system in the rat: Implications for the life prolonging effect of (-)deprenyl. Journal of Neural Transmission. Supple-mentum 60, 139-156.
223. Knoll J (2000) Outlines of a drug strategy to slow brain aging. Neuropsy-chopharmacologia Hungarica 11, 151-170.
224. Knuppel L and Linde K (2004) Adverse effects of St. John's Wort: A systematic review. Journal of Clinical Psychiatry 65, 1470-1479.
225. Ko RJ (1998) Adulterants in Asian patent medicines. New England Journal of Medicine 339, 847.
226. Kraft M, Spahn TW, Menzel J, et al. (2001) Fulminant liver failure after administration of the herbal antidepressant Kava-Kava. Deutsche Medizinische Wochenschrift 126, 970-972.
227. Krisanaprakornkit T, Krisanaprakornkit W, Piyavhatkul N, et al. (2006) Meditation therapy for anxiety disorders. The Cochrane Database of Systematic Reviews, CD004998.
228. Kruglikova RP (1997) How and why picamilon works. Life Extension 34-38.
229. Krystal AD and Ressler I (2002) The use of valerian in neuropsychiatry. CNS Spectrum 6, 841-847.
230. Kudolo GB (2000) The effect of 3-month ingestion of Ginkgo biloba extract on pancreatic beta-cell function in response to glucose loading in normal glucose tolerant individuals. Journal of Clinical Pharmacology 40, 647-654.
231. Kunz D and Bes F (1997) Melatonin effects in a patient with severe REM sleep behavior disorder: Case report and theoretical considerations. Neuropsychobiology 36, 211-214.
232. Kurkin VA and Zapesochnaya GG (1986) Khimicheskiy sostav i farmako-logicheskiye svoystva rasteniy roda Rhodiola. Obzor. (Chemical composition and pharmacological properties of Rhodiola rosea). Khim-Farm Zh (Chemical and Pharmaceutical Journal Moscow) 20, 1231-1244.
233. Kuttner L, Chambers CT, Hardial J, et al. (2006) A randomized trial of yoga for adolescents with irritable bowel syndrome. Pain Research and Management 11, 217-223.
234. Kyle DJ, Schaefer E, and Patton G (1998) Low serum docosahexanoic acid is a significant risk factor for Alzheimer's dementia. Presentation at the 3rd ISSFAL Congress, June 1-5, Lyons, France.
235. Lake JH and Spiegel DS (2007) Complementary and Alternative Treatments in Mental Health Care. American Psychiatric Press, Inc., Washington, DC, USA.
236. Larsen S (2006) The Healing Power of Neurofeedback. The Healing Press, Rochester, VT, USA.
237. Larsen S, Yee W, Gerbarg PG, et al. (2006) Neurophysiolgocial markers of Sudarshan Kriya Yoga practices: A pilot study. Preceedings World Conference Expanding Paradigms: Science, Consciousness and Spirituality. All India Institute of Medical Sciences, New Delhi, India, February 24-25. pp 36-48.
238. Lazar SW, Bush G, Gollub RL, et al. (2000) Functional brain mapping of the relaxation response and meditation. Neuroreport 11, 1581-1585.
239. Lazar SW, Kerr CE, Wasserman RH, et al. (2005) Meditation experience is associated with increased cortical thickness. Neuroreport 16, 1893-1897.
240. Le Bars PL, Velasco FM, Ferguson JM, et al. (2002) Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease. Neuropsychobiology 45, 19-26.
241. LeDoux JE (2000) Emotion Circuits in the brain. Annual Review of Neuroscience 23, 155-184.
242. Lee MS, Huh HJ, Kim BG, et al. (2002) Effects of Qi-training on heart rate variability. American Journal of Chinese Medicine 30, 463-470.
243. Lee MS, Kim MK, and Lee YH (2005a) Effects of Qi-therapy (external Qigong) on cardiac autonomic tone: A randomized placebo controlled study.International Journal of Neuroscience115(9), 1345-1350.
244. Lee MS, Rim YH, Jeong DM, et al. (2005b) Nonlinear analysis of heart rate variability during Qi therapy (external Qigong).American Journal of Chinese Medicine33(4), 579-588.
245. Lehmann D, Faber PL, Achermann P, et al. (2001) Brain sources of EEG gamma frequency during volitionally meditation-induced, altered states of consciousness, and experience of the self. Psychiatry Research 108, 111-121.
246. Lehmann E, Kinzler E, and Friedmann J (1996) Efficacy of a special kava extract (Piper methysticum) in patients with states of anxiety, tension, excitedness of nonmental origin-a double-blind, placebo-controlled study of four weeks treatment. Phytomedicine 3, 119-133.
247. Lehrer P, Sasaki Y, and Saito Y (1999) Zazen and cardiac variability. Psychosomatic Medicine 61, 812-821.
248. Lerner V, Kanevsky M, Dwolatzky T, et al. (2006) Vitamin B12 and folate serum levels in newly admitted psychiatric patients. Clinical Nutrition 25, 60-67.
249. Leverich GS and Post RM (2006) Course of bipolar illness after history of childhood trauma. Lancet 367, 1040-1042.
250. Levin HS (1991) Treatment of postconcussional symptoms with CDP-choline. Journal of the Neurological Sciences 103 (Suppl.), S39-S42.
251. Lieber CS (1999) Role of S-adenosyl-L-methionine in the treatment of liver diseases. Journal of Hepatology 30, 1155-1159.
252. Linde K, Ramirez G, Mulrow DF, et al. (1996) St. John's wort for depres-sion-an overview and meta-analysis of randomized clinical trials. British Medical Journal 313(7052), 253-258.
253. Long DA, Ghosh K, Moore AN, et al. (1996) Deferoxamine improves spatial memory performance following experimental brain injury in rats. Brain Research 717, 109-117.
254. Lozano R (1991) CDP-choline in the treatment of cranio-encephalic traumata. Journal of the Neurological Sciences 103 (Suppl.), S43-S47.
255. Lubar JF and Bahler WW (1976) Behavioral management of epileptic seizures following EEG biofeedback training of the sensorimotor rhythm. Biofeedback and Self Regulation 1, 77-104.
256. Lubar JO and Lubar JF (1984) Electroencephalographic biofeedback of SMR and beta for treatment of attention deficit disorders in a clinical setting. Biofeedback and Self Regulation 9, 1-23.
257. Lutz A, Greischar LL, Rawlings NB, et al. (2004) Long-term meditators self-induce high-amplitude gamma synchrony during mental practice. Proceedings of the National Academy of Sciences of the United States of America 101, 16369-16373.
258. Lyon MR, Cline JC, Totosy de Zepetnek J, et al. (2001) Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on atten-tion-deficit hyperactivity disorder: A pilot study. Journal of Psychiatry and Neuroscience 26, 221-228.
259. Maes M (1998) Fatty acids, cytokines, and major depression (editorial). Biological Psychiatry 42, 313-314.
260. Malathi A and Damodaran A (1999) Stress due to exams in medical students-role of yoga. Indian Journal of Physiology and Pharmacology 43, 218-224.
261. Mangoni A, Grassi MP, Frattola L, et al. (1991) Effects of a MAO-B inhibitor in the treatment of Alzheimer disease. European Neurology 31, 100-107.
262. Manjunath NK and Telles S (2005) Influence of Yoga and Ayurveda on selfrated sleep in a geriatric population. Indian Journal of Medical Research 121, 683-690.
263. Maruyama W and Naoi M (1999) Neuroprotection by (-)-deprenyl and related compounds. Mechanisms of Ageing and Development 111, 189-200.
264. Maslova LV, Kondrat'ev BIU, Maslov LN, et al. (1994) The cardioprotective and antiadrenergic activity of an extract of Rhodiola rosea in stress. Eksperimentalnaia I Klinicheskaia Farmakologiia 57, 61-63.
265. Mathews JD, Riley MD, Fejo L, et al. (1988) Effects of the heavy usage of kava on physical health: Summary of a pilot survey in an aboriginal community. Medical Journal of Australia 148, 548-555.
266. Mathews JM, Etheridge AS, Black SR et al. (2002) Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metabolism and Disposition: The Biological Fate of Chemicals 30, 1153-1157.
267. Mato JM, Camara J, Fernandez de Paz J, et al. (1999) S-adenosylmethio-nine in alcoholic liver cirrhosis: A randomized, placebo-controlled, double-blind, multicenter clinical trial. Journal of Hepatology 30, 1081-1089.
268. McCabe SE, Teter CJ, and Boyd CJ (2004) The use, misuse and diversion of prescription stimulants among middle and high school students. Substance Use and Misuse 39, 1095-1116.
269. McCann SM, Mastronardi C, de Laurentiis A, et al. (2005) The nitric oxide theory of aging revisited. Annals of the New York Academy of Sciences 1057, 64-84.
270. McDaniel MA, Maier SF, and Einstein GO (2003) "Brain-specific" nutrients: A memory cure? Nutrition 19, 957-975.
271. Meseguer E, Taboada R, Sanchez V, et al. (2002) Life-threatening parkinsonism induced by kava-kava. Movement Disorder 17(1), 195-196.
272. Mezzacappa E, Tremblay RE, Kindlon D, et al. (1996) Relationship of aggression and anxiety to autonomic regulation of heart rate variability in adolescent males. Annals of the New York Academy of Sciences 794, 376-379.
273. Mezzacappa E, Tremblay RE, Kindlon D, et al. (1997) Anxiety, antisocial behavior, and heart rate regulation in adolescent males. Journal of Child Psychology and Psychiatry and Allied Disciplines 38, 457-469.
274. Michalsen A, Grossman P, Acil A, et al. (2005) Rapid stress reduction and anxiolysis among distressed women as a consequence of a three-month intensive yoga program. Medical Science Monitor 11, CR555-CR561.
275. Milkiewicz P, Mills CO, Roma MG, et al. (1999) Tauroursodeoxycholate and S-adenosyl-l-methionine exert an additive ameliorating effect on taurolithocholate-induced cholestasis: A study in isolated rat hepatocyte couplets. Hepatology 29, 471-476.
276. Miller JJ, Fletcher K, and Kabat-Zinn J (1995) Three-year follow-up and clinical implications of a mindfulness-based stress reduction intervention in the treatment of anxiety disorders. General Hospital Psychiatry 17, 192-200.
277. Miller LG (1998) Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions. Archives of Internal Medicine 158, 2200-2211.
278. Mirzoian RS, Gan'shina TS, Kosoi MI, et al. (1989) Effect of pikamilon on the cortical blood supply and microcirculation in the pial arteriole system. Biulleten Eksperimentalnoi Biologii I Meditsiny 107, 581-582.
279. Mitka M (2002) News about neuroprotectants for the treatment of stroke. Journal of the American Medical Association 287, 1253-1254.
280. Miyake Y, Sasaki S, Tanaka K, et al. (2006) Dietary folate and vitamins B(12), B(6), and B(2) intake and the risk of postpartum depression in Japan: The Osaka Maternal and Child Health Study. Journal of Affective Disorders 96, 133-138.
281. Mizuhara H, Wang LO, Kobayashi K, et al. (2005) Long-range EEG phase synchronization during an arithmetic task indexes a coherent cortical network simultaneously measured by fMRI. Neuroimage 27, 553-563.
282. Monaco P, Pastore L, Rizzo S, et al. (1996) Safety and tolerability of adome-tionine (ADE) SD for inpatients with stroke: A pilot randomized, doubleblind, placebo-controlled study [abstract] presented at the Third World Stroke Conference and Fifth European Stroke Conference. Munich, Germany, September 1-5.
283. Monastra VJ, Monastra DM, and George S (2002) The effects of stimulant therapy, EEG biofeedback, and parenting style on the primary symptoms of attention-deficit/hyperactivity disorder. Applied Psychophysiology and Biofeedback 27(4), 231-249.
284. Morin CM, Koetter U, Bastien C, et al. (2005) Valerian-hops combination and diphenhydramine for treating insomnia: A randomized placebo-controlled clinical trial. Sleep 28, 1465-1471.
285. Morris MC, Evans DA, Bienias JL, et al. (2003) Dietary fats and the risk of incident Alzheimer disease. Archives of Neurology 60, 194-200.
286. Muller SF and Klement S (2006) A combination of valerian and lemon balm is effective in the treatment of restlessness and dyssomnia in children. Phytomedicine 13, 383-387.
287. Muller WE, Singer A, Wonnemann M, et al. (1998) Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry 31(Suppl. 1), 16-21.
288. Murdoch I, Perry EK, Court JA, et al. (1998) Cortical cholinergic dysfunction after human head injury. Journal of Neurotrauma 15, 295-305.
289. Muskin PR (ed) (2000) Complementary and alternative medicine and psychiatry. Review of Psychiatry, Vol. 19. Oldham JM and Riba MB (ed). American Psychiatric Press, Inc., Washington, DC, USA.
290. Nash JK (2000) Treatment of attention deficit hyperactivity disorder with neuro therapy. Clinical Electroencephalography 31, 30-37.
291. Negi KS, Singh YD, Kushwaha KP, et al. (2000) Clinical evaluation of memory enhancing properties of Memory Plus in children with attention deficit hyperactivity disorder. [Abstract]. Indian Journal of Psychiatry 42.
292. Nemets B, Stahl Z, and Belmaker RH (2002) Addition of omega-3 Fatty Acid to maintenance medication treatment for recurrent unipolar depressive disorder. American Journal of Psychiatry 159, 477-479.
293. Ng BY (1999) Qigong-induced mental disorders:A review. Australian and New Zealand Journal of Psychiatry 33, 197-206.
294. Nidecker A (1997) Probing genes, drugs, and fatty acids in dementia. Clinical Psychiatry News 4, xxxxx.
295. Nidich SI, Morehead P, Nidich RJ, et al. (1993) The effect of the Maharishi Student Rasayana food supplement on non-verbal intelligence. Personality and Individual Differences 15, 599-602.
296. Nierenberg AA, Burt T, Matthews J, et al. (1999) Mania associated with Stl John's Wort. Biological Psychiatry 46, 1707-1708.
297. Nierenberg AA, Ostacher MJ, Calabrese JR, et al. (2006) Treatment-resistant bipolar depression: A STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. American Journal of Psychiatry 163, 210-216.
298. Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, et al. (2005) Hydroalcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: A double-blind, randomized pilot trial. Journal of Ethnopharmacology 97, 281-284.
299. Ochs L (1994) EEG-driven Stimulation and heterogeneous head injured patients: Extended findings. A peer-reviewed abstract from the 1994 Berrol Head Injury Conference, Las Vegas, NV, USA. http://www.flexyx.com/contents/pubs/Extended.htm
300. Oken BS, Zajdel D, Kishiyama S, et al. (2006) Randomized, controlled, six-month trial of yoga in healthy seniors: Effects on cognition and quality of life. Alternative Therapies in Health and Medicine 12, 40-47.
301. Osher Y, Bersudsky Y, and Belmaker RH (2005) Omega-3 eicosapentaenoic acid in bipolar depression: Report of a small open-label study. Journal of Clinical Psychiatry 66, 726-729.
302. Osman E, Owen JS, and Burroughs AK (1993) Review article: S-adenosyl-L-methionine-a new therapeutic agent in liver disease? Alimentary Pharmacology and Therapeutics 7, 21-28.
303. Otero-Losada ME and Rubio MC (1989a) Acute changes in 5-HT metabolism after S-adenosyl-L-methionine administration.General Pharmacology20, 403-406.
304. Otero-Losada ME and Rubio MC (1989b) Acute effects of S-adenosyl-L-methionine on catecholaminergic central function.European Journal of Pharmacology163, 353-356.
305. Pandi-Perumal SR, Zisapel N, Srinivasan V, et al. (2005) Melatonin and sleep in aging population. Experimental Gerontology 40, 911-925.
306. Pandi-Perumal SR, Srinivasan V, Maestroni GJ, et al. (2006) Melatonin. FEBS Journal 273, 2813-2838.
307. Panossian A and Wagner H (2005) Stimulating effect of adaptogens: An overview with particular reference to their efficacy following single dose administration. Phytotherapy Research 19, 819-838.
308. Papakostas GIM (2006) Treatment-resistant major depressive disorder: New developments in 2006. 23, 17-20.
309. Paparrigopoulos TJ (2005) REM sleep behaviour disorder: Clinical profiles and pathophysiology. International Review of Psychiatry 17, 293-300.
310. Parker G, Gibson NA, Brotchie H, et al. (2006) Omega-3 fatty acids and mood disorders. American Journal of Psychiatry 163, 969-978.
311. Paul MA, Brown G, Buguet A, et al. (2001) Melatonin and zopiclone as pharmacologic aids to facilitate crew rest. Aviation, Space, and Environmental Medicine 72(11), 974-984.
312. Paul-Labrador M, Polk D, Dwyer JH, et al. (2006) Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Archives of Internal Medicine 166, 1218-1224.
313. Pavia J, Martos F, Gonzalez-Correa JA, et al. (1997) Effect of S-adeno-syl methionine on muscarinic receptors in young rats. Life Science 60, 825-832.
314. Pavlov VA and Tracey KJ (2005) The cholinergic anti-inflammatory pathway. Brain, Behavior, and Immunity 19, 493-499.
315. Peet M, Murphy B, Shay J, et al. (1998) Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biological Psychiatry 43, 315-319.
316. Pelka RB and Leuchtgens H (1995) Pre-Alzheimer study: Action of a herbal yeast preparation (Bio-Strath) in a randomised double-blind trial. Ars Medici-Zurich 85 (1), 54.
317. Peniston EG and Kulkosky PJ (1989) Alpha-theta brainwave training and beta-endorphin levels in alcoholics. Alcoholism, Clinical and Experimental Research 13, 271-279.
318. Penninx BWJH, Guralnik JM, Ferrucci L, et al. (2000) Vitamin B-12 deficiency and depression in physically disabled older women: Epidemiologic evidence from the Women's Health and Aging Study. American Journal of Psychiatry 157, 715-721.
319. Pepeu G, Pepeu IM, and Amaducci L (1996) A review of phosphatidylserine pharmacological and clinical effects. Is phosphatidylserine a drug for the ageing brain? Pharmacological Research 33, 73-80.
320. Petkov VD, Stancheva SL, Tocuschieva L, et al. (1990) Changes in brain biogenic monoamines induced by the nootropic drugs adafenoxate and meclofenoxate and by citicholine (experiments on rats). General Pharmacology 21, 71-75.
321. Petkov VD, Yonkov D, Mosharoff A, et al. (1986) Effects of alcohol aqueous extract from Rhodiola rosea L. roots on learning and memory. Acta Physiologica Et Pharmacologica Bulgarica 12, 3-16.
322. Pettegrew JW, Levine J, and McClure RJ (2000) Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: Relevance for its mode of action in Alzheimer's disease and geriatric depression. Molecular Psychiatry 5, 616-632.
323. Pezzoli C, Galli-Kienle M, and Stramentinoli G (1987) Lack of mutagenic activity of ademetionine in vitro and in vivo. Arzneimittelforschung 37, 826-829.
324. Philippot P, Gaetane C, and Blairy S (2002) Respiratory feedback in the generation of emotion. Cognition and Emotion 16, 605-607.
325. Piscitelli SC, Burstein AH, Chaitt D, et al. (2000) Indinavir concentrations and St John's wort. Lancet 355, 547-548.
326. Pittler MH and Ernst E (2000) Efficacy of kava extract for treating anxiety: Systematic review and meta-analysis. Journal of clinical Psychopharmacology 20, 84-89.
327. Raison CL, Capuron L, and Miller AH (2006) Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends in Immunology 27, 24-31.
328. Ramassamy C (2006) Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular targets. European Journal of Pharmacology 545, 51-64.
329. Ramirez PM, Desantis D, and Opler LA (2001) EEG biofeedback treatment of ADD. A viable alternative to traditional medical intervention? Annals of the New York Academy of Sciences 931, 342-358.
330. Raskin M, Bali LR, and Peeke HV (1980) Muscle biofeedback and transcendental meditation. A controlled evaluation of efficacy in the treatment of chronic anxiety. Archives of General Psychiatry 37, 93-97.
331. Rasmusson AM, Vasek J, Lipschitz DS, et al. (2004) An increased capacity for adrenal DHEA release is associated with decreased avoidance and negative mood symptoms in women with PTSD. Neuropsychopharmacology 29, 1546-1557.
332. Richardson AJ (2006) Omega-3 fatty acids in ADHD and related neurode-velopmental disorders. International Review of Psychiatry 18, 155-172.
333. Riggs K, Spiro A III, and Tucker K, et al. (1996) Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. American Journal of Clinical Nutrition 63, 306-314.
334. Robbins J (2000) A Symphony in the brain: The evolution of the new brain wave biofeedback. Atlantic Monthly Press, New York, NY, USA.
335. Rosenbaum JF, Fava M, Falk WE, et al. (1990) The antidepressant potential of oral S-adenosyl-l-methionine. Acta Psychiatrica Scandinavica 81, 432-436.
336. Rozelle GR and Budzynski TH (1995) Neurotherapy for stroke rehabilitation: A single case study. Biofeedback and Self Regulation 20, 211-228.
337. Ruschitzka F, Meier PJ, Turina M, et al. (2000) Acute heart transplant rejection due to Saint John's Wort. Lancet 355, 548-549.
338. Rush AJ, Trivedi MH, Wisniewski SR, et al. (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry 163, 1905-1917.
339. Russello D, Randazzo G, Favetta A, et al. (1990) Oxiracetam treatment of exogenous postconcussion syndrome. Statistical evaluation of results. Minerva Chirurgica 45, 1309-1314.
340. Sackeim HA, Keilp JG, Rush AJ, et al. (2001) The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 14, 53-62.
341. Saeed RW, Varma S, Peng-Nemeroff T, et al. (2005) Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. Journal of Experimental Medicine 201, 1113-1123.
342. Sageman S (2002) How SK can treat the cognitive, psychodynamic, and neuropsychiatric problems of posttraumatic stress disorder. Presented at An International Symposium on Sudarshan Kriya, Pranayam and Consciousness, New Delhi, India, March 2-3.
343. Sageman S (2004) Breaking through the despair: Spiritually oriented group therapy as a means of healing women with severe mental illness. Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry 32, 125-141.
344. Sageman S and Brown RP (2006b) 3-acetyl-7-oxo-dehydroepiandrosterone for healing treatment-resistant posttraumatic stress disorder in women: 5 case reports.Journal of Clinical Psychiatry67, 493-496.
345. Sageman S and Brown R (2006a) Free at last: Natural and conventional treatment of a patient with multiple comorbid psychiatric disorders. In DSM-IV-TR Case Book. Vol. 2, Spitzer RL, First MB, Williams JBW Gibbon M (eds). American Psychiatric Publishing, Inc., Washington, DC, USA, pp 109-121.
346. Sakakibara M and Hayano J (1996) Effect of slowed respiration on cardiac parasympathetic response to threat. Psychosomatic Medicine 58, 32-37.
347. Salem N Jr. (1989) Omega-3-fatty acids: Molecular and chemical aspects. In New Roles for Selective Nutrients, Spiller GA and Scala L (eds). Alan R Liss, New York, NY, USA, pp 109-228.
348. Salem N Jr., Kim NY, and Yergey JA (1986) Docosohexanoic acid: Membrane function and metabolism. In Health Effects of Polyunsaturated Seafoods, Simopoulos A, Kifer RR, and Martin R (eds). Academic Press, New York, NY, USA, pp 263-317.
349. Salmaggi P, Bressa GM, Nicchia G, et al. (1993) Double-blind, placebo-controlled study of S-adenosyl-l-methionine in depressed postmenopausal women. Psychotherapy and Psychosomatics 59, 34-40.
350. Sano M (2003) Noncholinergic treatment options for Alzheimer's disease. Journal of Clinical Psychiatry 64 (Suppl 9), 23-28.
351. Saratikov AS and Krasnov EA (1987a) Effect of Rhodiola rosea on the central nervous system. In Rhodiola Rosea is a Valuable Medicinal Plant (Golden Root), Saratikov AS and Krasnov EA (eds). Tomsk State University, Tomsk, Russia, pp 150-179.
352. Saratikov AS and Krasnov EA (1987b) Clinical studies of Rhodiola. In Rhodiola Rosea is a Valuable Medicinal Plant (Golden Root), Saratikov AS and Krasnov EA (eds). Tomsk State University, Tomsk, Russia, pp 216-227.
353. Saratikov AS and Krasnov EA (1987c) Rhodiola Rosea is a Valuable Medicinal Plant (Golden Root).Tomsk State University, Tomsk, Russia.
354. Satyanarayana M, Rajeswari KR, Rani NJ, et al. (1992) Effect of Santhi Kriya on certain psychophysiological parameters: A preliminary study. Indian Journal of Physiology and Pharmacologgy 36(2), 88-92.
355. Scarmeas N, Stern Y, Mayeux R, et al. (2006) Mediterranean diet, Alzheimer disease, and vascular mediation. Archives of Neurology 63, 1709-1717.
356. Schardt D (2000) St. John's worts and all. Nutrition Action Healthletter (September), 6-8.
357. Schaumburg HH and Berger A (1992) Alopecia and sensory polyneuropathy from thallium in a Chinese herbal medication. Journal of the American Medical Association 268, 3430-3431.
358. Schellenberg R, Sauer S, and Dimpfel W (1998) Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG. Pharmacopsychiatry 31(Suppl. 1), 44-53.
359. Schenck CH, Bundlie SR, and Ettinger MG (1986) Chronic behavioral disorders of REM sleep: A new category of parasomnia. Sleep 9. 293-308.
360. Schmidt RH and Grady MS (1995) Loss of forebrain cholinergic neurons following fluid-percussion injury: Implications for cognitive impairment in closed head injury. Journal of Neurosurgical 83, 496-502.
361. Schoenthaler SJ and Bier ID (1999) Vitamin-mineral intake and intelligence: A macrolevel analysis of randomized controlled trials. Journal of Alternative and Complementary Medicine 5, 125-134.
362. Schoenberger NE, Shif SC, Esty ML, et al. (2001) Flexyx Neuro therapy System in the treatment of traumatic brain injury: An initial evaluation. Journal of Head Trauma Rehabilitation 16, 260-274.
363. Schrader E (2000) Equivalence of St John's wort extract (Ze 117) and fluoxetine: A randomized, controlled study in mild-moderate depression. International Clinical Psychopharmacology 15, 61-68.
364. Scott GN and Elmer GW (2002) Update on natural product-drug interactions. American Journal of Health-System Pharmacy 59, 339-347.
365. Shamir E, Laudon M, Barak Y, et al. (2000) Melatonin improves sleep quality of patients with chronic schizophrenia. Journal of Clinical Psychiatry 61, 373-377.
366. Shannahoff-Khalsa DS (2003) Kundalini yoga meditation techniques for the treatment of obsessive-compulsive and OC spectrum disorders. Grief Treatment and Crisis Intervention 3, 369-382.
367. Shannahoff-Khalsa DS (2004) An introduction to Kundalini yoga meditation techniques that are specific for the treatment of psychiatric disorders. Journal of Alternative and Complementary Medicine 10, 91-101.
368. Shannahoff-Khalsa DS, Ray LE, Levine S, et al. (1999) Randomized controlled trial of yogic meditation techniques for patients with obsessive-compulsive disorder. CNS Spectrums 4, 34-47.
369. Sharma R, Chaturvedi C, and Tewari PV (1987) Efficacy of Bacopa mon-nieri in revitalizing intellectual functions in children. Journal of Research and Education in Indian Medicine 30, 1-12.
370. Shelton RC, Keller MB, Gelenberg A, et al. (2001) Effectiveness of St John's wort in major depression: A randomized controlled trial. Journal of the American Medical Association 285, 1978-1986.
371. Shevtsov VA, Zholus BI, Shervarly VI, et al. (2003) A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine 10(2-3), 95-105.
372. Singh YN and Blumenthal M (1996) Kava: An overview. Herbalgram Special Review 39, 33-55.
373. Singh YN and Devkota AK (2003) Aqueous kava extracts do not affect liver function tests in rats. Planta Medica 69, 496-499.
374. Smits MG, Nagtegaal EE, van der Heijden J, et al. (2001) Melatonin for chronic sleep onset insomnia in children: A randomized placebo-controlled trial. Journal of Child Neurology 16(2), 86-92.
375. Smits MG, van Stel HF, van der Heijden K, et al. (2003) Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: A randomized placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry 42(11), 1286-1293.
376. Snayder NA, Agarkova NO, Lyulyakina EG, et al. (2006) The biolelectrical brain activity in humans who practiced Sudarshan Kriya. Proceedings World Conference Expanding Paradigms: Science, Consciousness and Spirituality. All India Institute of Medical Sciences, New Delhi, India, February 24-25.
377. Soderberg M, Edlund C, Kristensson K, et al. (1991) Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 26, 421-425.
378. Sontrop J and Campbell MK (2006) Omega-3 polyunsaturated fatty acids and depression: A review of the evidence and a methodological critique. Preventive Medicine 42, 4-13.
379. Sorensen H and Sonne J (1996) A double-masked study of the effects of ginseng on cognitive functions. Current Therapeutic Research 57, 959-968.
380. Sotaniemi EA, Haapakoski E, and Rautio A (1995) Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 18, 1373-1375.
381. Sovik R (2000) The science of breathing-the yogic view. Progress in Brain Research 122, 491-505.
382. Spasov AA, Wikman GK, Mandrikov VB, et al. (2000) A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine 7, 85-89.
383. Spiers PA and Hochanadel G (1999) Citicoline for traumatic brain injury: Report of two cases, including my own. Journal of the International Neuropsychological Society 5, 260-264.
384. Srinivasan V, Pandi-Perumal S, Cardinali D, et al. (2006) Melatonin in Alzheimer's disease and other neurodegenerative disorders. Behavioral and Brain Functions 2, 15.
385. Stancheva SL and Mosharrof A (1987) Effect of the extract of Rhodiola rosea L. on the content of the brain biogenic monoamines. Medecine Physiologie Comptes Rendus de l'Academie Bulgare des Sciences 40, 85-87.
386. Sterman MB and Macdonald LR (1978) Effects of central cortical EEG feedback training on incidence of poorly controlled seizures. Epilepsia 19, 207-222.
387. Stevens LJ, Zentall SS, Deck JL, et al. (1995) Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. American Journal of Clinical Nutrition 62, 761-768.
388. Stevinson C and Ernst E (2000) Valerian for insomnia: Systematic review of randomized placebo-controlled studies. Sleep Medicine 1, 91-99.
389. Stoll AL, Sachs GS, Cohen BM, et al. (1996) Choline in the treatment of rapid-cycling bipolar disorder: Clinical and neurochemical findings in lithium-treated patients. Biological Psychiatry 40, 382-388.
390. Stoll AL, Severus WE, Freeman MP, et al. (1999) Omega 3 fatty acids in bipolar disorder. Archives of General Psychiatry 56, 407-412.
391. Stramentinoli G (1987) Pharmacologic aspects of S-adenosylmethionine. Pharmacokinetics and pharmacodynamics. American Journal of Medicine 83, 35-42.
392. Stratyner HB (2006) Multi-factorial Approaches to Substance Use Disorders and Addiction. CNS Spectrums 11, 828.
393. Sublette ME, Russ MJ, and Smith GS (2004) Evidence for a role of the ara-chidonic acid cascade in affective disorders: A review. Bipolar Disorders 6, 95-105.
394. Suhner A, Schlagenhauf P, Johnson R, et al. (1998) Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag. Chronobiology International 15(6), 655-666.
395. Surtees R and Hyland K (1989) A method for the measurement of S-adeno-sylmethionine in small volume samples of cerebrospinal fluid or brain using high-performance liquid chromatography-electrochemistry. Analytical Biochemistry 181, 331-335.
396. Szegedi A, Kohnen R, Dienel A, et al. (2005) Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): Randomised controlled double blind non-inferiority trial versus paroxetine. British Medical Journal 330, 503.
397. Takahashi J, Nishino H, and Ono T (1986) Effect of S-adenosyl-l-methio-nine (SAMe) on disturbances in hand movement and delayed response tasks after lesion of motor or prefrontal cortex in the monkey. Nippon Yakurigaku Zasshi. Folia Pharmacologica Japonica 87, 507-519.
398. Takahashi J, Nishino H, and Ono T (1987) S-adenosyl-l-methionine facilitates recovery from deficits in delayed response and hand movement tasks following brain lesions in monkeys. Experimental Neurology 98, 459-471.
399. Tallal P, Chase C, Russell G, et al. (1986) Evaluation of the efficacy of piracetam in treating information processing, reading and writing disorders in dyslexic children. International Journal of Psychophysiology 4, 41-52.
400. Tang XC (1996) Huperzine A (shuangyiping): A promising drug for Alzheimer's disease. Zhongguo Yao Li Xue Bao 17, 481-484.
401. Telles S, and Desiraju T (1992) Heart rate and respiratory changes accompanying yogic conditions of single thought and thoughtless states. Indian Journal of Physiology and Pharmacology 36(4), 293-294.
402. Teter CJ, McCabe SE, Cranford JA, et al. (2005) Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. Journal of American College Health 53, 253-262.
403. Thayer JF and Brosschat JF (2005) Psychosomatics and psychopathology: Looking up and down from the brain. Psychoneuroendocrinology 30(10), 1050-1058.
404. The US Department of Health and Human Services Agency for Healthcare Research and Quality (2002) S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease. Evidence Report/Technology Assessment No. 64; www.ahrq.gov.
405. Thiele B, Brink I, and Ploch M (1994) Modulation of cytokine expression by hypericum extract. Journal of Geriatric Psychiatry and Neurology 7 (Suppl. 1), S60-S62.
406. Thommessen B and Laake K (1996) No identifiable effect of ginseng (Geri-complex) as an adjuvant in the treatment of geriatric patients. Aging (Milano) 8, 417-420.
407. Tildesley NT, Kennedy DO, Perry EK, et al. (2005) Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers. Physiology and Behavior 83(5), 699-709.
408. Torrioli MG, Vernacotola S, Mariotti P, et al. (1999) Double-blind, placebo-controlled study of l-acetylcarnitine for the treatment of hyperactive behavior in fragile X syndrome. American Journal of Medical Genetics 87, 366-368.
409. Torta R, Zanalda F, Rocca P, et al. (1988) Inhibitory activity of S-adenosyl-l-methionine on serum gamma-glutamyl-transpeptidase increase induced by psychodrugs and anticonvulsants. Current Therapeutic Research 44, 144-159.
410. Tracey KJ (2005) Fat meets the cholinergic antiinflammatory pathway. Journal of Experimental Medicine 202, 1017-1121.
411. Trebatická J, Kopasova S, Hradecna Z, et al. (2006) Treatment of ADHD with French maritime pine bark extract, Pycnogenol. European Child and Adolescent Psychiatry 15, 329-335.
412. Unutzer J, Klap R, Sturm R, et al. (2000) Mental disorders and the use of alternative medicine: Results from a national survey. American Journal of Psychiatry 157, 1851-1857.
413. US Food and Drug Administration Center for Food Safety and Applied Nutrition (2002) Kava-containing dietary supplements may be associated with severe liver injury (Mar 25). http://www.cfsan.fda.gov/~dms/addskava.html.
414. van Niekerk JK, Hup pert FA, and Herbert J (2001) Salivary cortisol and DHEA: Association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation. Psycho neuroendocrinology 26, 591-612.
415. Vaschillo E, Vaschillo B, and Lehrer P (2004) Heartbeat synchronizes with respiratory rhythm only under specific circumstances. Chest 126, 1385-1386.
416. Vastag B (2001) Pay attention: Ritalin acts much like cocaine. Journal of the American Medical Association 286, 905-906.
417. Vellas B, Andrieu S, Ousset PJ, et al. (2006) The GuidAge study: Methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761(R) for prevention of Alzheimer disease in patients over 70 with a memory complaint. Neurology 67, S6-S11.
418. Vernon MW and Sorkin EM (1991) Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders. Drugs Aging 1, 17-35.
419. Voelker R (1999) Herbs and anethesia. Journal of the American Medical Association 281, 1882.
420. Volkow ND, Chang L, Wang GJ, et al. (2001a) Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers.American Journal of Psychiatry158, 383-389.
421. Volkow ND, Chang L, Wang GJ, et al. (2001b) Association of dopamine transporter reduction with psychomotor impairment in methampheta-mine abusers.American Journal of Psychiatry158, 377-382.
422. Volkow ND, Wang G, Fowler JS, et al. (2001c) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.Journal of Neuroscience 21, RC121.
423. Volz HP and Kieser M (1997) Kava-kava extract WS 1490 versus placebo in anxiety disorders-a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry 30, 1-5.
424. Vorbach EU, Arnoldt KH, and Hubner WD (1997) Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. Pharmacopsychiatry 30(Suppl. 2), 81-85.
425. Wang R, Yan H, and Tang XC (2006) Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta pharmacologica Sinica 27, 1-26.
426. Wagner H (1999) Phytomedicine research in Germany. Environmental Health Perspectives 107, 779-781.
427. Warnecke G (1991) Psychosomatische dysfunktionen im weiblichen klimak-terium. Fortschritte Der Medizin 109, 119-122.
428. Watson CG, Tuorila JR, Vickers KS, et al. (1997) The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. Journal of Clinical Psychology 53, 917-923.
429. Weintraub A (2004) Yoga for Depression: A Compassionate Guide to Relieve Suffering Through Yoga. Broadway Books of Random House, Inc., New York, NY, USA.
430. Wesnes KA, Faleni RA, Hefting NR, et al. (1997) The cognitive, subjective, and physical effects of a ginkgo biloba/panax ginseng combination in healthy volunteers with neurasthenic complaints. Psychopharmacology Bulletin 33, 677-683.
431. Wheatley D (1999) Hypericum in seasonal affective disorder (SAD). Current Medical Research and Opinion 15, 33-37.
432. Willatts P, Forsyth JS, DiModugno MK, et al. (1998) Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 352, 688-691.
433. Wilsher CR, Bennett D, Chase CH, et al. (1987) Piracetam and dyslexia: Effects on reading tests. Journal of Clinical Psychopharmacology 7, 230-237.
434. Wolkowitz OM, Reus VI, Keebler A, et al. (1999) Double-blind treatment of major depression with dehydroepiandrosterone. American Journal of Psychiatry 156, 646-649.
435. Wong AH, Smith M, and Boon HS (1998) Herbal remedies in psychiatric practice. Archives of General Psychiatry 55, 1033-1043.
436. Woolery A, Meyers H, Sternlieb B, et al. (2004) A yoga intervention for young adults with elevated symptoms of depression. Alternative Therapies 10, 60-63.
437. Wright DW, Kellermann AL, Hertzberg VS, et al. (2006) ProTECT: A Randomized Clinical Trial of Progesterone for Acute Traumatic Brain Injury. Annals of Emergency Medicine.
438. Xu R, Zhao W, Xu J, et al. (1996) Studies on bioactive saponins from Chinese medicinal plants. Advances in Experimental Medicine and Biology 404, 371-382.
439. Yen SS (2001) Dehydroepiandrosterone sulfate and longevity: New clues for an old friend. Proceedings of the National Academy of Sciences of the United States of America 98, 8167-8169.
440. Youdim KA, Martin A, and Joseph JA (2000) Essential fatty acids and the brain: Possible health implications. International Journal of Developmental Neuroscience 18, 383-399.
441. Yu J (2005) Airway mechanosensors. Respiratory Physiology and Neurobiology 148, 217-243.
442. Zanardi R and Smeraldi E (2006) A double-blind, randomised, controlled clinical trial of acetyl-l-carnitine vs. amisulpride in the treatment of dys-thymia. European Neuropsychopharmacology 16, 281-287.
443. Zandi PP, Anthony JC, Khachaturian AS, et al. (2004) Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: The Cache County Study. Archives of Neurology 61, 82-88.
444. Zhang XY, Zhou DF, Zhang PY, et al. (2001) A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia. Journal of Clinical Psychiatry 62, 878-883.
445. Zhang ZJ, Kang WH, Li Q, et al. (2006) The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: Double-blind, placebo-controlled studies. Journal of Psychiatric Research.
446. Zhdanova IV, Wurtman RJ, Regan MM, et al. (2001) Melatonin treatment for age-related insomnia. Journal of Clinical Endocrinology and Metabolism 86, 4727-4730.
447. Zhu J, Hamm RJ, Reeves TM, et al. (2000) Postinjury administration of L-deprenyl improves cognitive function and enhances neuroplasticity after traumatic brain injury. Experimental Neurology 166, 136-152.
448. Zs-Nagy I (1994) A survey of the available data on a new nootropic drug, BCE-001. Annals of the New York Academy Science 717, 102-114.